Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types

Journal of General Virology

Volumn 80, Issue 6, 1999, Pages 1513-1517

  Thomas, Miranda ^a   Banks, Lawrence ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAK; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRUS REPLICATION; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0032977612     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-6-1513     Document Type: Article

References (21)

1. Bandara, L., Adamczewski, J., Hunt, T. & LaThangue, N. (1991). Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature 352, 249-251.
2. Blanton, R., Coltrera, M., Gown, A., Halbert, C. & McDougall, J. (1992). Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels. Cell Growth & Differentiation 3, 791-802.
3. Chellappan, S., Kraus, V., Kroger, B., Münger, K., Howley, P., Phelps, W. & Nevins, J. (1992). Adenovirus E1A, simian virus 40 tumour antigen and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proceedings of the National Academy of Sciences, USA 89, 4549-4553.
4. Cheng, S., Schmidt-Grimminger, D., Murant, T., Broker, T. & Chow, L. (1995). Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes & Development 9, 2335-2349.
5. Chittenden, T., Flemington, C., Houghton, A., Ebb, R., Gallo, G., Elangovan, B., Chinnadurai, G. & Lutz, R. (1995). A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO Journal 14, 5589-5596.
6. Doorbar, J., Foo, C., Coleman, N., Medcalf, L., Hartley, O., Prospero, T., Napthine, S., Sterling, J., Winter, G. & Griffin, H. (1997). Characterisation of events during the late stages of HPV-16 infection using high affinity synthetic FAbs to E4. Virology 238, 40-52.
7. Dyson, N., Howley, P., Münger, K. & Harlow, E. (1989). The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934-936.
8. Huang, D., Cory, S. & Strasser, A. (1997). Bcl-2, Bcl-XL and adenovirus protein E1B are functionally equivalent in their ability to inhibit cell death. Oncogene 14, 405-414.
9. Huibregtse, J., Scheffner, M. & Howley, P. (1991). A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO Journal 10, 4129-4135.
10. Huibregtse, J., Scheffner, M. & Howley, P. (1993). Localisation of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Molecular and Cellular Biology 13, 4918-4927.
11. Krajewski, S., Krajewska, M., Shabaik, A., Miyashita, T., Wang, H. & Reed, J. (1994). Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. American Journal of Pathology 145, 1323-1336.
12. Krajewski, S., Krajewska, M. & Reed, J. (1996). Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Research 56, 2849-2855.
13. Morris, J., Crook, T., Bandara, L., Davies, R., LaThangue, N. & Vousden, K. (1993). Human papillomavirus type 16 E7 regulates E2F and contributes to mitogenic signalling. Oncogene 8, 893-898.
14. Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
15. Pagano, M., Dürst, M., Joswig, S., Draetta, G. & Jansen-Dürr, P. (1992). Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalised cells. Oncogene 7, 1681-1686.
16. Pan, H. & Griep, A. (1995). Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes & Development 9, 2157-2169.
17. Phelps, W., Bagchi, S., Barnes, J., Raychaudhuri, P., Kraus, V., Münger, K., Howley, P. & Nevins, J. (1991). Analysis of transactivation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism. Journal of Virology 65, 6922-6930.
18. Reed, J. (1994). Bcl-2 and the regulation of programmed cell death. Journal of Cell Biology 124, 1-6.
19. Scheffner, M., Werness, B., Huibregtse, J., Levine, A. & Howley, P. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.
20. Thomas, M. & Banks, L. (1998). Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 17, 2943-2954.
21. Werness, B., Levine, A. & Howley, P. (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248, 76-79.